LOS COLEGIOS PROFESIONALES Y LA LEY 2/2023 SOBRE PROTECCIÓN DE INFORMANTES (I)

Los distintos Colegios Profesionales se encuentran comprendidos en el ámbito personal de la Ley 2/2023 como consecuencia de lo establecido en el artículo 13 de la misma:

Artículo 13. Entidades obligadas en el sector público.

1. Todas las entidades que integran el sector público estarán obligadas a disponer de un Sistema interno de información en los términos previstos en esta ley.

A los efectos de esta ley se entienden comprendidos en el sector público:

a) La Administración General del Estado, las Administraciones de las comunidades autónomas, ciudades con Estatuto de Autonomía y las entidades que integran la Administración Local.

b) Los organismos y entidades públicas vinculadas o dependientes de alguna Administración pública, así como aquellas otras asociaciones y corporaciones en las que participen Administraciones y organismos públicos.

c) Las autoridades administrativas independientes, el Banco de España y las entidades gestoras y servicios comunes de la Seguridad Social.

d) Las universidades públicas.

e) Las corporaciones de Derecho público.

f) Las fundaciones del sector público. A efectos de esta ley, se entenderá por fundaciones del sector público aquellas que reúnan alguno de los siguientes requisitos:

1.º Que se constituyan de forma inicial, con una aportación mayoritaria, directa o indirecta, de una o varias entidades integradas en el sector público, o bien reciban dicha aportación con posterioridad a su constitución.

2.º Que el patrimonio de la fundación esté integrado en más de un cincuenta por ciento por bienes o derechos aportados o cedidos por sujetos integrantes del sector público con carácter permanente.

3.º Que la mayoría de derechos de voto en su patronato corresponda a representantes del sector público.

g) Las sociedades mercantiles en cuyo capital social la participación, directa o indirecta, de entidades de las mencionadas en las letras a), b), c), d) y g) del presente apartado sea superior al cincuenta por ciento, o en los casos en que, sin superar ese porcentaje, se encuentre respecto de las referidas entidades en el supuesto previsto en el artículo 5 del texto refundido de la Ley del Mercado de Valores, aprobado por Real Decreto Legislativo 4/2015, de 23 de octubre.

2. También deberán dotarse de un Sistema interno de información, en los mismos términos requeridos para las entidades del sector público enunciados en el apartado anterior, los órganos constitucionales, los de relevancia constitucional e instituciones autonómicas análogas a los anteriores.

3. En caso de organismos públicos con funciones de comprobación o investigación de incumplimientos sujetos a esta norma, se distinguirá, al menos, entre un canal interno referente a los propios incumplimientos del organismo o su personal, y el canal externo referente a las comunicaciones que reciba de los incumplimientos de terceros cuya investigación corresponda a sus competencias.

4. En caso de que un organismo público con competencias en materia de investigación reciba informaciones referentes a los incumplimientos de terceros en el plazo de duración establecido en la letra d) del artículo 9.2, se resolverá si procede o no iniciar una comprobación o investigación del sujeto afectado dando traslado de ello al informante.

Una vez ultimado el procedimiento de comprobación o investigación, se comunicará al informante el resultado de la comprobación. Si los datos e informes que figuran en el expediente tienen carácter reservado o confidencial de acuerdo con alguna disposición con rango de ley, el contenido del resultado que se traslade al informante tendrá carácter genérico.

5. Las decisiones adoptadas por los organismos públicos con funciones de comprobación o investigación en relación con las informaciones no serán recurribles en vía administrativa ni en vía contencioso-administrativa.

El régimen sancionador aplicable es el general, con la particularidad de que el mismo no distingue entre canal interno y externo del Colegio:

Artículo 63. Infracciones.

1. Tendrán la consideración de infracciones muy graves las siguientes acciones u omisiones dolosas:

a) Cualquier actuación que suponga una efectiva limitación de los derechos y garantías previstos en esta ley introducida a través de contratos o acuerdos a nivel individual o colectivo y en general cualquier intento o acción efectiva de obstaculizar la presentación de comunicaciones o de impedir, frustrar o ralentizar su seguimiento, incluida la aportación de información o documentación falsa por parte de los requeridos para ello.

b) La adopción de cualquier represalia derivada de la comunicación frente a los informantes o las demás personas incluidas en el ámbito de protección establecido en el artículo 3 de esta ley.

c) Vulnerar las garantías de confidencialidad y anonimato previstas en esta ley, y de forma particular cualquier acción u omisión tendente a revelar la identidad del informante cuando este haya optado por el anonimato, aunque no se llegue a producir la efectiva revelación de la misma.

d) Vulnerar el deber de mantener secreto sobre cualquier aspecto relacionado con la información.

e) La comisión de una infracción grave cuando el autor hubiera sido sancionado mediante resolución firme por dos infracciones graves o muy graves en los dos años anteriores a la comisión de la infracción, contados desde la firmeza de las sanciones.

f) Comunicar o revelar públicamente información a sabiendas de su falsedad.

g) Incumplimiento de la obligación de disponer de un Sistema interno de información en los términos exigidos en esta ley.

2. Tendrán la consideración de infracciones graves las siguientes acciones u omisiones:

a) Cualquier actuación que suponga limitación de los derechos y garantías previstos en esta ley o cualquier intento o acción efectiva de obstaculizar la presentación de informaciones o de impedir, frustrar o ralentizar su seguimiento que no tenga la consideración de infracción muy grave conforme al apartado 1.

b) Vulnerar las garantías de confidencialidad y anonimato previstas en esta ley cuando no tenga la consideración de infracción muy grave.

c) Vulnerar el deber de secreto en los supuestos en que no tenga la consideración de infracción muy grave.

d) Incumplimiento de la obligación de adoptar las medidas para garantizar la confidencialidad y secreto de las informaciones.

e) La comisión de una infracción leve cuando el autor hubiera sido sancionado por dos infracciones leves, graves o muy graves en los dos años anteriores a la comisión de la infracción, contados desde la firmeza de las sanciones.

3. Tendrán la consideración de infracciones leves las siguientes acciones u omisiones:

a) Remisión de información de forma incompleta, de manera deliberada por parte del Responsable del Sistema a la Autoridad, o fuera del plazo concedido para ello.

b) Incumplimiento de la obligación de colaboración con la investigación de informaciones.

c) Cualquier incumplimiento de las obligaciones previstas en esta ley que no esté tipificado como infracción muy grave o grave.

Sanciones

Artículo 65. Sanciones.

1. La comisión de infracciones previstas en esta ley llevará aparejada la imposición de las siguientes multas:

a) Si son personas físicas las responsables de las infracciones, serán multadas con una cuantía de 1.001 hasta 10.000 euros por la comisión de infracciones leves; de 10.001 hasta 30.000 euros por la comisión de infracciones graves y de 30.001 hasta 300.000 euros por la comisión de infracciones muy graves.

b) Si son personas jurídicas serán multadas con una cuantía hasta 100.000 euros en caso de infracciones leves, entre 100.001 y 600.000 euros en caso de infracciones graves y entre 600.001 y 1.000.000 de euros en caso de infracciones muy graves.

2. Adicionalmente, en el caso de infracciones muy graves, la Autoridad Independiente de Protección del Informante, A.A.I., podrá acordar:

a) La amonestación pública.

b) La prohibición de obtener subvenciones u otros beneficios fiscales durante un plazo máximo de cuatro años.

c) La prohibición de contratar con el sector público durante un plazo máximo de tres años de conformidad con lo previsto en la Ley 9/2017, de 8 de noviembre, de Contratos del Sector Público, por la que se transponen al ordenamiento jurídico español las Directivas del Parlamento Europeo y del Consejo 2014/23/UE y 2014/24/UE, de 26 de febrero de 2014.

Concurrencia de regímenes sancionadores

Artículo 67. Concurrencia.

El ejercicio de la potestad sancionadora previsto en este título es autónomo y podrá concurrir con el régimen disciplinario del personal funcionario, estatutario o laboral que resulte de aplicación en cada caso.

El Real Decreto 1101/2024, de 29 de octubre, por el que se aprueba el Estatuto de la Autoridad Independiente de Protección del Informante, A.A.I., que entró en vigor el 1 de noviembre, precisa lo siguiente en su Preámbulo:

La Ley 2/2023, de 20 de febrero, además de autorizar la creación de la Autoridad Independiente de Protección del Informante, A.A.I., regula cuestiones tales como la naturaleza del ente, sus funciones y las reglas básicas de su régimen jurídico en materia de personal, contratación, régimen patrimonial, de asistencia jurídica, régimen presupuestario, de contabilidad y control económico y financiero, de recursos, potestad sancionadora, y la forma y requisitos de las circulares y recomendaciones que puede adoptar.

La Autoridad Independiente de Protección del Informante, A.A.I., es un ente con autonomía e independencia funcional cuyo objetivo último es cumplir el mandato de Ley 2/2023, de 20 de febrero; como norma que contiene el criterio de las instituciones de la Unión Europea respecto de la necesidad de establecer un marco jurídico armonizado para toda la Unión en el que cada Estado miembro deberá ajustar el contenido de sus normas internas para implementar un régimen jurídico que garantice una protección efectiva de aquellas personas que, en el seno de organizaciones públicas o privadas, comuniquen información relativa a infracciones del Derecho de la Unión, y por lo tanto, perjudiciales para el interés público.

El real decreto consta de un artículo único que dispone la aprobación del Estatuto orgánico de la Autoridad Independiente de Protección del Informante, A.A.I., así como de una disposición transitoria, una derogatoria, y una final que prevé la entrada en vigor del presente real decreto el día siguiente al de su publicación en el «Boletín Oficial del Estado».

 

"LA IMPLOSIÓN DEL BANCO JAPONÉS NORINCHUKIN" (19-02-2025+9-04-2025)

Japan is about to wreck the Globe.

Reverse carry trade is underway.

Tariffs were simply the trigger for what might be a chain reaction. https://t.co/wSscOVPj9e

— Guillermo Ruiz Zapatero (@ruiz_zapatero) April 9, 2025

https://t.co/ntRvLAVgww
LA IMPLOSIÓN DEL BANCO JAPONÉS NORINCHUKIN https://t.co/jpx49n88YF

— Guillermo Ruiz Zapatero (@ruiz_zapatero) April 9, 2025

La crítica no es menos necesaria que la acción@NorthmanTrader https://t.co/axd8pTtusv

— Guillermo Ruiz Zapatero (@ruiz_zapatero) April 9, 2025

"If these tariffs go through as they currently are and stick the US will enter a recession and millions would lose their jobs as everything is so interconnected." https://t.co/VlBnWaj6TB

— Guillermo Ruiz Zapatero (@ruiz_zapatero) April 9, 2025

LA IMPLOSIÓN DEL BANCO JAPONÉS NORINCHUKIN

 

 

NORINCHUKIN BANK IMPLOSION OFFICIALLY BEGINS (19-02-2025)

During the last quarter alone, Norinchukin Bank incurred a ~500bn JPY net income loss, bringing the total for the first quarters of this fiscal year to ~1.4trillion JPY, equivalent to ~9.2bn USD. Where do these losses come from? They come entirely from Norinchukin Bank’s securities portfolio, which shrank from ~38 trillion JPY to ~35.6 trillion JPY at the end of December 2024. From another perspective, this means that Norinchukin lost ~20% on a 2.4 trillion JPY face value of assets liquidated.

If we already apply the ~20% discount on the real price that the bank could fetch in the market to the ~35.6 trillion JPY of Securities left in its portfolio, the unrealized losses instead are ~7.12 trillion JPY. Considering that the bank only has ~4 trillion JPY of Net Assets left, it is becoming harder and harder for the Bank of Japan and the Japanese government to hide the fact that the second largest bank in the country is more and more insolvent and in desperate need of a bailout to stay in business.

 One thing that struck me the most in the latest Norinchukin Bank financial report is the table “Summary of Performance” which you can see below. Please take a look at the metrics for the third quarter of 2024. Do you notice anything incredible? Yes, my dear reader: EVERY SINGLE PERFORMANCE LINE IS NEGATIVE.

So why did Norinchukin sell all those securities in the last quarter and crystallize such a large amount of losses previously hidden in the hold-to-maturity books? Because the bank’s liquidity crisis is worsening:

• Deposits fell in one quarter from ~58.9 trillion JPY to 57.9 trillion JPY
• Repurchase Agreements (in Liabilities, hence money borrowed against collateral) fell in one quarter from ~9.3 trillion JPY to ~6.2 trillion JPY

Total = minus 4.1 trillion JPY

The bank has been trying to raise capital since May last year (Japan’s Norinchukin Bank eyes raising $7.7bn in fresh capital), but as I flagged already at that time, whoever could read and properly analyze the books of the bank knew they were already insolvent and hiding a massive hole. Considering how much liquidity is being printed non-stop by central banks these days and how bullish stock markets are, if Norinchukin cannot raise capital in the best possible market conditions, then its fate is sealed and in the near future it is doomed to implode unless the government steps in with a massively expensive bailout. Failure to bail out this bank will have incredible repercussions in the global financial system, similar to those that would have occurred if Credit Suisse was let to collapse. The problem here is that governments will not be able to afford to bail out all these giant banks forever, and the scary thing is so many are in this very same situation and I won’t stop warning about it.

ENTRADAS DEL BLOG REFERIDAS AL COVID-19 (ENTRE EL 11-10-2021 Y EL 31-12-2022, (II))

 

Time for Big Pharma to come clean on what and when they knew about mRNA injection adverse events. https://t.co/VLLbHkb7U7

— Senator Ron Johnson (@SenRonJohnson) April 4, 2025

#LYNNMARGULIS

"LIFE DID NOT TAKE OVER THE WORLD BY COMBAT, BUT BY NETWORKING"

SYNTHETIC VIRUS (SARS-Cov-2) COULD HAVE TAKEN OVER THE WORLD BY "HUMAN" COMBAT https://t.co/iEt5Uw8HbJ pic.twitter.com/IeX8MH2ULE

— Guillermo Ruiz Zapatero (@ruiz_zapatero) October 22, 2022

¿POR QUÉ SE VA A #VACUNAR A LOS #NIÑOS CONTRA EL #COVID-19? (V, TOBY ROGERS; #NUMERODEVACUNACIONESNECESARIAS) https://t.co/26c2nWOqHT

Con arreglo al modelo de riesgo y beneficio explicado en la publicación enlazada, salvar una vida con la vacuna causaría 2,84 fallecimientos

— Guillermo Ruiz Zapatero (@ruiz_zapatero) November 7, 2021

 

 

(Estas entradas, publicadas aquí entre el 11-10-2021 y e 31-12-2022, como las anteriores y las que seguirán, ponen de manifiesto que todas las cuestiones relevantes relacionadas con el virus, la vacunación y las cuestiones legales vinculadas a la misma, eran patentes desde el origen de la crisis, así como que su falta de difusión y debate público obedeció exclusiva o principalmente al control de la información llevado a cabo por las distintas autoridades a nivel mundial, europeo y nacional.

La investigación y sus consecuencias legales y difusión pública son ahora más importantes que nunca.)

LA OBLIGACIÓN DE LOS PASAPORTES COVID-19 EN EL ÁMBITO LABORAL EN ITALIA (I)

https://gruizlegal.blogspot.com/2021/10/la-obligacion-de-los-pasaportes-covid.html

LA OBLIGACIÓN DE LOS PASAPORTES COVID-19 EN EL ÁMBITO LABORAL EN ITALIA (II)

https://gruizlegal.blogspot.com/2021/10/la-obligacion-de-los-pasaportes-covid_13.html

 

¿POR QUÉ SE VA A VACUNAR A NIÑOS CONTRA EL COVID-19?

https://gruizlegal.blogspot.com/2021/10/por-que-se-va-vacunar-ninos-contra-el.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (II, PROFFESOR DR. HARVEY RISCH (YALE))

https://gruizlegal.blogspot.com/2021/10/por-que-se-va-vacunar-los-ninos-contra.html

(video no disponible)

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (III,  EL PECADO IMPERDONABLE, GEERT VANDEN BOSSCHE)

https://gruizlegal.blogspot.com/2021/10/por-que-se-va-vacunar-los-ninos-contra_27.html

Opinion LEGAL

8 de octubre de 2021

The unforgivable sin

As the mechanism of immune defense in vaccinees is totally different from the one at play in unvaccinated individuals, the mantra of mass vaccination stakeholders that vaccination of youngsters and children will provide them with improved protection from contracting severe disease is a textbook example of scientific nonsense. Their irrational, erroneous extrapolations lead people to believe that they should get their children vaccinated whereas there is barely any more catastrophic immune intervention one could think of. In line with the intrinsic functional properties of innate, multi-specific Abs, healthy children and youngsters are NOT ‘naturally’ susceptible to any Sars-CoV-2 lineage but exclusively acquire such susceptibility as a direct consequence of functional suppression of their well-established innate immune capacity due to a rapid re-exposure event or, even much worse and long-lived, due to vaccination. The likelihood of rapid re-exposure to Sars-CoV-2 after previous infection dramatically increases when highly infectious variants expand in prevalence. Such an expansion in prevalence directly results from mass vaccination campaigns as mass vaccination turns vaccinees into an excellent breeding ground for naturally selected S-directed immune escape variants.

So, unless there is any contradiction in the above reasoning and unless somebody could explain how similar viral replication and transmission dynamics in vaccinated as compared to unvaccinated individuals could lead to dissimilar clinical manifestations of infection, we can only conclude that the scenario is the following: Vaccination of children and youngsters is turning off their broadly protective innate immunity in exchange for S-specific vaccinal Abs that are becoming increasingly useless since their neutralizing capacity becomes more and more eroded as a result of enhanced escape of Sars-CoV-2 from neutralizing Abs [NAbs](a trend that has been clearly confirmed by molecular epidemiologists (8)). Resistance to the neutralizing effect of vaccinal Abs that are nevertheless still able to bind Sars-CoV-2 virions and thereby outcompete protective innate Abs is likely to enhance the susceptibility of vaccinees to ADE (Ab-dependent enhancement of disease).

SOLAMENTE PODEMOS CONCLUIR LO SIGUIENTE: LA VACUNACIÓN DE ÑIÑOS Y JÓVENES ESTÁ SUPRIMEINDO SU AMPLIA PROTECCIÓN INMUNE INNATA A CAMBIO DE ANTICUERPOS VACINALES ESPECÍFICOS CONTRA LA ESPÍCULA QUE SON CRECIENTEMENTE INÚTILES PUESTO QUE SU CAPACIDAD DE NEUTRALIZACIÓN ES MÁS Y MÁS EROSIONADA COMO RESULTADO DEL ESCAPE PROMOVIDO DEL COVID A LOS ANTICUERPOS NEUTRALIZADORES (NAbs),UNA TENDENCIA CONFIRMADA POR EPIDEMIÓLOGOS MOLECULARES (. LA RESISTENCIA AL EFECTO NEUTRALIZADOR DE LOS ANTICUERPOS VACINALES QUE SIN EMBARGO SON CAPACES TODAVÍA DE VINCULARSE A LOS VIRIONES DEL COVID Y POR TANTO DESACTIVAR LOS ANTICUERPOS PROTECTORES INNATOS PROMOVERÁ PREVISIBLEMENTE LA SUSCEPTIBILIDAD DE LOS VACUNADOS A ADE (REFUERZO DE LA ENFERMEDAD DEPENDIENTE DE LOS ANTICUERPOS)

Unless virology and immunology are being rewritten, I cannot imagine how mass vaccination of our youngsters and children will not lead to an even more disastrous outcome of all the scientifically irrational and unjustifiable vaccination efforts. Not only will this dramatically increase the children’s risk to succumb to (accelerated) Covid-19 disease but it will also take away the highly efficient capacity of healthy, unvaccinated people to diminish the dangerous, ever rising viral infectious pressure in the population. By vaccinating our youngsters, children and, even more generally, all people in excellent health, we deprive an important part of the population from its ‘anti-viral’ capacity and instead turn them into a breeding ground for more infectious and increasingly NAb-resistant variants. In other words, mass vaccination of children will inevitably obstruct the process of building herd immunity in the population. While unvaccinated children who contract Covid-19 disease in the vast majority of cases don’t suffer severe disease and contribute to the buildup of herd immunity in the population, mass vaccination campaigns in children will prevent them from contributing to herd immunity, because more infectious viral variants are increasingly escaping from neutralization by vaccinal anti-S Abs and gaining a significant fitness advantage in such an immunological environment.

A MENOS QUE LA VIROLOGÍA Y LA INMUNOLOGÍA SEAN REESCRITAS, NO PUEDO IMAGINAR QUE LA VACUNACIÓN MASIVA DE JÓVENES Y NIÑOS NO CONDUZCA A UN RESULTADO INCLUSO MÁS DESASTROSO QUE TODOS LOS ESFUERZOS IRRACIONALES E JUSTIFICABLES DE VACUNACIÓN.NO SOLO AUMENTARA EL RIESGO DE LOS ÑIÑOS DE SUCUMBIR A UNA (ACELERADA) ENFERMEDAD COVID SINO QUE TAMBIÉN ELIMINARÁ LA ALTAMENTE EFICIENTE CAPACIDAD DE GENTE SANA NO VACUNADA DE DISMINUIR LA PELIGROSA Y SIEMPRE CRECIENTE PRESIÓN VIRAL INFECCIOSA EN LA POBLACIÓN.AL VACUNAR A NUESTROS JÓVENES, NIÑOS Y, MÁS EN GENERAL, A GENTE EN BUEN ESTADO DE SALUD, PRIVAMOS A UNA PARTE IMPORTANTE DE LA POBLACIÓN DE DE SU CAPACIDAD "ANTI-VIRAL" Y EN SU LUGAR LOS CONVERTIMOS EN UN CAMPO ABONADO PARA MÁS INFECCIOSAS Y CRECIENTEMENTE RESISTENTES N-Ab VARIEDADES. EN OTRAS PALABRAS LA MASIVA VACUNACIÓN DE ÑIÑOS INEVITABLMENTE OBSTRUIRÁ EL PROCESO DE LA CONSTRUCCIÓN DE UNA INMUNIDAD DE GRUPO EN LA POBLACIÓN.MIENTRAS LOS ÑIÑOS NO VACUNADOS QUE CONTRAEN COVID NO SUFREN EN LA INMENSA MAYORÍA DE LOS CASOS UNA ENFERMEDAD SEVERA Y CONTRIBUYEN A CONSTRUIR LA INMUNIDAD DE GRUPO EN LA POBLACIÓN, LAS CAMPAÑAS MASIVAS DE VACUNACIÓN EN LOS NIÑOS IMPEDIRÁN SU CONTRIBUCIÓN A LA INMUNIDAD DE GRUPO, PORQUE VARIEDADES DEL VIRUS MÁS INFECCIOSAS CRECIENTEMENTE ESCAPAN DE LA NEUTRALIZACIÓN DE LOS ANTICUERPOS VACINALES CONTRA LA ESPÍCULA Y OBTIENEN UNA SIGNIFICATIVA VENTAJA EN TAL MEDIO INMUNOLÓGICO.

There can be no doubt that large scale immune interventions which ignore the immune pathogenesis of the disease are recipes for massive disasters.

NO PUEDE HABER DUDA QUE LAS INTERVENCIONES INMUNES A GRAN ESCALA QUE IGNORAR LA PATOGÉNESIS INMUNE DE LA ENFERMEDAD SON RECETAS PARA DESASTRES MASIVOS.

It cannot be that highly knowledgeable vaccinologists don’t understand this clear-cut message. I can only shout at all of them, no matter their international reputation, the number of awards and recognitions they’ve gotten, the number of books they’ve written or high-ranked papers they’ve published in peer-reviewed journals: shame on you for not standing up

NO PUEDE SER EL CASO QUE ALTAMENTE REPUTADOS VACINOLOGOS NO ENTIENDAN ESTE MENSAJE CLARO.SOLAMENTE PUEDO GRITARLES, SIN IMPORTAR SU REPUTACIÓN INTERNACIONAL, EL NUMERO DE PREMIOS Y RECONOCIMIENTOS QUE HAN RECIBIDO, EL NÚMERO DE LIBROS Y TRABAJOS DESTACADOS QUE HAN PUBLICADO EN REVISTAS CIENTÍFICAS: LA VERGÜENZA SOBRE VOSOTROS POR NO OPONEROS

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19 (IV, TOBY ROGERS; NUMERO DE VACUNACIONES NECESARIAS)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (V, TOBY ROGERS; NUMERO DE VACUNACIONES NECESARIAS)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_6.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (VI, TOBY ROGERS; NÚMERO DE VACUNACIONES NECESARIAS)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_62.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (VII, TOBY ROGERS; NÚMERO DE VACUNACIONES NECESARIAS)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_54.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (VIII, OMS, CONSENTIMIENTO IMPLÍCITO)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_7.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (IX, OMS CONSENTIMIENTO IMPLÍCITO)

https://www.blogger.com/blog/post/edit/8156865/7884895915976906683

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (X, OMS, CONSENTIMIENTO IMPLÍCITO)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_43.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19?

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-avacunar-los-ninos-contra.html

¿POR QUÉ SE VA A VACUNAR A LOS NIÑOS CONTRA EL COVID-19? (CHINA)

https://gruizlegal.blogspot.com/2021/11/por-que-se-va-vacunar-los-ninos-contra_8.html

LAS OBLIGACIONES DE VACUNACIÓN COVID-19 Y EL TEOREMA DE IMPOSIBILIDAD DE ARROW

https://gruizlegal.blogspot.com/2021/11/las-obligaciones-de-vacunacion-covid-19.html

SSRN: COVID-19 VACCINE MANDATES AND ARROW'S IMPOSSIBILITY THEOREM

https://gruizlegal.blogspot.com/2021/12/ssrn-covid-19-vaccines-madates-and.html

Opinion LEGAL

15 de diciembre de 2021

Your paper, "#COVID-19 #VACCINE #MANDATES AND #ARROW'S #IMPOSSIBILITY #THEOREM", was recently listed on #SSRN's #Top #Ten download list for: #Biology & #Law #eJournal.

As of 15 December 2021, your paper has been downloaded 17 times. You may view the abstract and download statistics at: https://lnkd.in/dSXhG_xv.

Top Ten Lists are updated on a daily basis. Click the following link(s) to view the Top Ten list for:

Biology & Law eJournal Top Ten.

LAS VACUNACIONES COVID Y EL INFORME DE LA CANADIAN COVID CARE ALLIANCE

https://gruizlegal.blogspot.com/2021/12/las-vacunaciones-covid-y-el-informe-de_29.html

LAS VACUNACIONES COVID Y EL INFORME DE LA CANADIAN COVID CARE ALLIANCE: DERECHO TRIBUTARIO Y CONSTITUCIONAL DERECHO Y NUEVAS TECNOLOGIAS ACTUALIDAD JURIDICA Y ECONOMICA MEDIOAMBIENTE, ENLACE A LA PUBLICACIÓN https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf Y VIDEO https://www.canadiancovidcarealliance.org/media-resources/the-pfizer-inoculations-for-covid-19-more-harm-than-good-2/

ANALISIS BIG DATA MUNDIAL DE EFECTOS DE LAS VACUNAS EN LOS FALLECIMIENTOS Y CASOS ASOCIADOS A COVID-19

https://gruizlegal.blogspot.com/2022/01/analisis-big-data-mundial-de-efectos-de.html

If there comes another Great Leap Forward someday (YAN LIANKE)

https://gruizlegal.blogspot.com/2022/01/if-there-comes-another-great-leap.html

Who erased our memories and wiped them clean?

Forgetful people are, in essence, dirt in the fields and on the roads. Grooves on the sole of a shoe can step on them in whichever way they please.

Forgetful people are, in essence, woodblocks and planks that have cut ties with the tree that gave them life. Saws and axes are in full control of what they become in the future.

If reporters do not report what they witness, and authors do not write about their memories and feelings; if the people in society who can talk and know how to talk are always recounting, reading, and proclaiming in pure lyrical political correctness, who can tell us what it means to live on this earth as flesh and blood?

Imagine this: the author Fang Fang did not exist in today’s Wuhan. She did not keep records or pen down her personal memories and feelings. Neither were there tens of thousands of people who were like Fang Fang and would send out loud cries for help via their mobile phones. What would we have heard? What would we have seen?

Flesh and blood, body and soul are gone. All is well, and the little fulcrum of truth that could lift the world is lost. As such, history becomes a collection of legends, of lost and imagined stories, that are baseless and unfounded. From this perspective then, how important it is that we can remember, and possess our own memories that are neither revised nor erased. It is the least amount of certainty and evidence that we can provide when we speak a little truth.

Memories cannot change the world, but it gives us a genuine heart.

If there comes another Great Leap Forward someday and people revert to using backyard furnaces, it can at least convince us that sand will not turn into iron, and one mu [a unit of measurement, approximately 667 sqm] of yield will not weigh 100,000 catties. We will at least know that this is the most basic common sense, and not some miracle of consciousness producing matter, or air creating food. If there’s another Cultural Revolution of some sort, we’ll at least be able to guarantee that we will not land our parents in prison or on the guillotine.

Because of this, I hope that each of you, and all of us who’ve experienced the catastrophic Covid-19 will become people who remember; people who derive memories from memory.

Writing poems after the Auschwitz concentration camp period was indeed barbaric, but it is even more barbaric if we simply choose to forget it in words, in conversations and in memories—it is indeed much more barbaric and horrifying.

If we can’t be a whistle-blower like Li Wenliang, then let us at least be someone who hears that whistle.

If we can’t speak out loudly, then let us be whisperers. If we can’t be whisperers, then let us be silent people who have memories. Having experienced the start, onslaught, and spread of Covid-19, let us be the people who silently step aside when the crowd unites to sing a victory song after the battle is won—the people who have graves in their hearts, with memories etched in them; the people who remember and can someday pass on these memories to our future generations.

YAN LIANKE

https://lithub.com/yan-lianke-what-happens-after-coronavirus/

UN MODELO DE CONSENTIMIENTO INFORMADO PARA LAS VACUNAS COVID-19 (I)

https://gruizlegal.blogspot.com/2022/01/un-modelo-de-consentimiento-informado.html

UN MODELO DE CONSENTIMIENTO INFORMADO PARA LAS VACUNAS COVID-19 (II)

https://gruizlegal.blogspot.com/2022/01/un-modelo-de-consentimiento-informado_18.html

 

UN MODELO DE CONSENTIMIENTO INFORMADO PARA LAS VACUNAS COVID-19 ((III), TRADUCCIÓN AL CASTELLANO)

https://gruizlegal.blogspot.com/2022/01/un-modelo-de-consentimiento-informado_50.html

Risk from Covid-19

El riesgo del Covid-19

Conozco que el riesgo de fallecimiento derivado de una infección por SAR-CoV-2 es aproximadamente el mostrado en la tabla adjunta para cada grupo de edad:

Conozco que si me encuentro sano, mi riesgo es incluso inferior que el antes mostrado para mi grupo de edad, en la medida que el 95% de los fallecimientos ocurren en personas con una o más comorbilidades. Solamente individuos de alto riesgo (principal mente personas de más de 50 años con problemas de salud previos) son susceptibles de una enfermedad grave y potencialmente mortal por Covid-19. La mediana de edad de fallecimiento por Covid-19 es similar a la de la mortalidad natural en la mayoría de los países.

Conozco que la persistencia de síntomas en pacientes con alto riesgo después de enfermedad grave es común a todos los virus respiratorios (p.e., gripe). La referencia de un Covid duradero en grupos de bajo riesgo parece ser de origen psicosomático y debido a expectativas infundadas de malos desenlaces (niños, adolescentes y adultos). El Covid duradero no es una preocupación para individuos con bajo riego.

Risk from the Covid-19 injections

El riesgo de las vacunas Covid-19

Conozco que los potenciales efectos secundarios de las vacunas Covid-19 incluyen:

(…)

 

Conozco que ha habido un incremento superior al 1.000% en los efectos adversos registrados por vacunas Covid-19 en comparación a todas las vacunas previas en el sistema VAERS (USA) de registro de efectos adversos. Un registro inferior al número de casos es una debilidad bien documentada del sistema VAERS. Los casos registrados pueden ser una estimación a la baja de los verdaderos casos de efectos adversos.

Conozco que el riesgo de un efecto adverso cardíaco para jóvenes entre 12-15 años es de cuatro a seis veces el riesgo de su hospitalización.

Conozco que el riesgo de miocarditis es seis veces superior en el grupo de 15 años después de la segunda dosis y que el 72% de todas las miocarditis registradas están vinculadas a gente joven de entre 10 y 30 años de edad.

Conozco que no hay información referida al medio o largo plazo y que la misma será difícil de obtener dados que los fabricantes de las vacunas eliminaron el grupo de control después de la autorización de uso urgente (EUA) al administrar también la vacuna a los participantes en el grupo de control.

Conozco que el m-RNA contenido en las vacunas COVI-19 circula en la sangre y es distribuido a diferentes órganos como el cerebro, la médula, el bazo, el hígado, glándulas suprarrenales, ovarios, etc. El m-RNA codifica la proteína de la espícula- un agente biológico tóxico y activo. Puede unirse a células en diferentes órganos, dando lugar posiblemente a daño en los tejidos o causando una reacción autoinmune (en la que el cuerpo ataca sus propias células porque las mismas muestran un marcador ajeno -la espícula de la proteína- en su superficie). Ver referencias de grupos médicos sobre una variedad de preocupaciones acerca de las vacunas Covid-19.

Benefits of the Covid-19 injections

El beneficio de las vacunas Covid-19

Conozco que los datos de los fabricantes sobre la eficacia de las vacunas Covid-19 en la reducción de la enfermedad grave todavía no ha sido replicados por científicos independientes. Los fabricantes informaron de la reducción relativa del riesgo (RRR- reducción del riesgo en el grupo que recibió la inyección comparado con el grupo placebo). Esta medición no tiene en cuenta el riesgo de los participantes en contraer la enfermedad, o el su riesgo de enfermedad grave por COVID-19,que se expresa como reducción de riesgo absoluta (ARR). La ARR de las vacunas COVID-19 es muy inferior a su RRR.

Conozco que ninguna de las pruebas realizadas ha demostrado una reducción en la hospitalización o muerte como consecuencia de las vacunas Covid-19.

Disadvantages of the Covid-19 injections

Desventajas de las vacunas Covid-19

Conozco que Pfizer, Moderna, Astra-Zeneca, Johnson and Johnson, y Sputnik, son todas terapias génicas nunca ensayadas antes de los actuales programas de vacunación. No son vacunas tradicionales que usan un virus inactivado o parte de un virus. En la actualidad (noviembre de 2021 y USA), no hay vacunas Covid-19 aprobadas por un órgano regulador. Todas las vacunas en el mercado tuvieron una autorización de uso por emergencia (EUA) y no han seguido el complejo proceso requerido para una aprobación completa. Al aceptar estas vacunas, estoy aceptando participar en estas pruebas clínicas.

Conozco que si me vacuno, puedo contraer el virus y trasmitirlo a otros de la misma manera que una persona no vacunada.

Conozco que posiblemente experimentaré una reducción de mi inmunidad en las dos semanas posteriores a cada vacuna, que me someterá a un riesgo mayor de contraer Covid-19 y desarrollar la enfermedad. Ello puede explicar el incremento del número de muertes en varios países después de la vacunación.

Conozco que no estoy contribuyendo a la inmunidad de grupo con las vacunas en la medida en que la vacuna proporciona solo una protección limitada de corta duración, y las dosis de refuerzo  pueden no ser efectivas contra las nuevas variantes.

Conozco que el SARS-CoV-2 no puede ser erradicado en la medida que también se transmite entre animales y que permanecerá como una parte del reservorio de virus con los que convivimos

Available alternative treatment

Tratamiento alternativo disponible

Conozco que hay disponible un tratamiento profiláctico ( medicamentos tales como Ivermectin y suplementos como Vitaminas C y D, y Zinc) para los individuos de riesgo que previene la infección o reduce la gravedad de la enfermedad

Conozco que el tratamiento precoz ha estado disponible para pacientes de alto riego desde Agosto de 2020.Se estima que el tratamiento precoz reduce la hospitalización en un 88% y los fallecimientos en un 75%.

Conozco que hay medicamentos seguros y efectivos para tratar a los pacientes de alto riesgo.

Conozco que tres anticuerpos monoclonales (anticuerpos producidos en el laboratorio que se unen y neutralizan la proteína de la espícula del virus) y plasma convaleciente (plasma de pacientes recuperados que contiene sus anticuerpos) han sido aprobados bajo autorizaciones de urgencia para la prevención y el tratamiento del Covid-19 en pacientes de alto riesgo. La inclusión de anticuerpos monoclonales en el tratamiento precoz ha mostrado una reducción en la hospitalización o fallecimiento del 70%.

Contraindications

Contraindicaciones

Conozco que los siguientes grupos fueron excluidos de las pruebas clínicas: mujeres embarazadas, individuos previamente infectados, individuos con desórdenes autoinmunes, individuos alérgicos a alguno de los componentes de las vacunas o con una previa reacción alérgica a una vacuna. Por ello no hay actualmente información disponible sobre seguridad o eficacia para estos grupos.

Conozco que las vacunas están contraindicadas para las personas recuperadas de la enfermedad, en la medida que son más proclives a experimentar una reacción adversa que los individuos sin previa exposición al virus.

Conozco que las vacunas están contraindicadas para los que han experimentado una seria reacción alérgica a cualquier vacuna o a cualquier ingrediente de la vacuna.

Conozco que si estoy embarazada mi riesgo de aborto espontáneo puede ser superior después de la vacuna al promedio de pérdida de embarazo en circunstancias ordinarias.

Conozco que los efectos a largo plazo sobre el feto son actualmente desconocidos.

Conozco que la inmunidad natural es más amplia y duradera que la inmunidad no esterilizante y la inmunidad transitoria proporcionada por las vacunas, y que es la opción preferible para los individuos de bajo riesgo (menores de 60 años sin ninguna comorbilidad)

Conozco que no hay pruebas clínicas que evalúen la seguridad y eficacia de recibir combinaciones de vacunas de diferentes fabricantes (vacunación heteróloga). Tampoco hay información sobre interacciones adversas entre las mismas.

General Terms

Condiciones Generales

I understand that neither the clinician administering the injection, nor the manufacturers of the injections, nor the site where the injection is administered, nor the government are liable for any adverse event I may experience following the injection, whether the injections are found to be directly causal of the adverse events or not.

(Translation omitted. Not applicable in signatory countries of the Oviedo Convention in the opinion of the translator)

I understand that I have the responsibility to report any adverse events following vaccination to my family physician or file a report on the adverse events reporting system in my country whether I believe the symptoms experienced are caused by the injection or not.

(Translation omitted, see below)

I understand that such reporting is essential to detect potential unpredicted harm following the rollout of a new medical product.(Adverse events reporting systems: UK, US, Canada, Germany, Europe, South Africa, Austria,Switzerland, New Zealand, Australia, France)

(Translation omitted. In Spain no national reporting system available different from EUDRA VIGILANCE))

I understand that I must remain on site for 15-30 minutes following the administration of the Covid-19 injection for monitoring in case of an anaphylactic reaction.

(Translation omitted)

Conozco que mi información sanitaria, y mi estatus de vacunación, están protegidos por la ley. Que no estoy obligado a compartir mi información de salud para acceder a locales o servicios o para trasladarme de una parte a otra en mi país.

Conozco que como ciudadano, libremente tengo el derecho de consentimiento informado y autonomía corporal. Por ello tengo el derecho de aceptar o rechazar esta vacuna o cualquier vacuna de refuerzo sin necesidad de invocar ninguna razón o explicación.

Recipient agreement

Conformidad del vacunado

El firmante plenamente capaz consiente la vacunación y declara comprender todos los elementos anteriores y que no se encuentra sometido a ninguna presión, engaño o cualquier otra forma de intimidación

(Pandemic Data and Analytics by Abir Ballan. November 2021; https://www.pandata.org/)

MUERTES POR COVID-19 EN INGLATERRA SEGÚN ESTATUS DE VACUNACIÓN (1-01-2021-31-10-2021, (I))

https://gruizlegal.blogspot.com/2022/01/muertes-por-covid-19-en-inglaterra_30.html

MUERTES POR COVID-19 EN INGLATERRA SEGÚN ESTATUS DE VACUNACIÓN (1-01-2021-31-10-2021, (II)

https://gruizlegal.blogspot.com/2022/01/muertes-por-covid-19-en-inglaterra_30.html

MUERTES POR TODAS LAS CAUSAS EN INGLATERRA SEGÚN ESTATUS DE VACUNACIÓN ( GRUPOS 10-19 AÑOS, (III))

https://gruizlegal.blogspot.com/2022/01/muertes-por-todas-las-causas-en.html

According to the ONS, between 2nd January and 31st October 2021 there were 96 deaths recorded among 10-14-year-olds who had not been vaccinated, and 160 deaths recorded among 15-19-year-olds who had not been vaccinated.

The ONS have calculated the person-years among unvaccinated 10-14 year-olds during this period to be 2,094,711, whilst they’ve calculated person-years among unvaccinated 15-19 year-olds during this period to be 1,587,072.

To work out the mortality-rate per 100,000 person years all we need to now do is divide the person-years by 100,000, and then divide the number of deaths by the answer to that equation.

So for 10-14 year-olds we perform the following calculation –

2,094,711 (person-years) / 100,000 = 20.94711

96 (deaths) / 20.94711 = 4.58

Therefore, the mortality rate per 100,000 person-years among unvaccinated 10-14-year-olds is 4.58 deaths per 100,000 person-years between 1st Jan and 31st Oct 21.

By using the same formula we find that the the mortality rate among unvaccinated 15-19-year-olds is 10.08 deaths per 100,000 person-years.

Now all we have to do is use the same formula to calculate the mortality rate among one-dose vaccinated and two dose vaccinated 10-14, and 15-19 year-olds, by using the person-years and number of deaths provided by the ONS in table 9 of their ‘Deaths by Vaccination Status’ report, which are as follows –

 

 

 

 

If the Covid-19 injections were not causing untimely deaths within the group then we would actually expect to see a mortality rate that is lower among the vaccinated population than the mortality rate among the unvaccinated population, not a mortality rate that is similar, and certainly not a mortality rate that is substantially higher

 

PETICIÓN DE MÉDICOS Y CIENTÍFICOS AL PARLAMENTO EUROPEO SOBRE LA VACUNACIÓN COVID-19 INFANTIL

https://gruizlegal.blogspot.com/2022/01/peticion-de-medicos-y-cientificos-al.html

HALLAZGOS CARDIACOS HISTOPATOLÓGICOS EN AUTOPSIA POST VACUNACIÓN COVID-19 DE DOS ADOLESCENTES (I)

 

https://gruizlegal.blogspot.com/2022/02/hallazgos-cardiacos-histopatologicos-en.html

HALLAZGOS CARDIACOS HISTOPATOLÓGICOS EN AUTOPSIA POST VACUNACIÓN COVID-19 DE DOS ADOLESCENTES (II)

https://gruizlegal.blogspot.com/2022/02/hallazgos-cardiacos-histopatologicos-en_15.html

EL TRIBUNAL SUPREMO DE LA INDIA Y LAS OBLIGACIONES DE VACUNACIÓN COVID (I)

https://gruizlegal.blogspot.com/2022/05/el-tribunal-supremo-de-la-india-y-las.html

On May 2, in a landmark judgment, India’s Supreme Court, the highest court in the land, ruled that “no one can be forced to be vaccinated” and that “bodily integrity and personal autonomy” are protected under the law as a constitutional right. Citing emerging scientific opinion “which appears to indicate that the risk of transmission of the virus from unvaccinated individuals is almost on par with that from vaccinated persons,” the judicial bench went on to argue that since infection rates are currently low, restrictions imposed on the unvaccinated, including those that curtail their freedom of movement and access to welfare and other services, are not “proportionate,” and urged organizations that imposed these restrictions to review these measures and modify them as necessary.

The court was responding to a plea filed by a former member of the country’s national advisory group on immunization, seeking disclosure on vaccine clinical trials and the posting of vaccination-adverse events data. The plea argued that Indian states’ legislation mandating vaccination for government employees and as a precondition for accessing welfare and other services, including travel in public transport, was a violation of basic individual rights and, therefore, unconstitutional.

The federal government in India itself has not issued any vaccine mandates and has always maintained that it is a voluntary, individual choice. The judgment was rendered even more extraordinary by the fact the directives were limited to the “present situation alone,” and the court upheld government restrictions on the unvaccinated “if the situation so warrants,” thereby striking a delicate balance between a person’s right to choose and the government’s responsibility in protecting public health.

What is fascinating is that this extraordinary Supreme Court judgment in India is in the context of a Westminster system, a system originating in the United Kingdom but also, of course, shared by Canada. Unlike in the United States, with its tradition of activist courts that are not shy to push back against the executive or legislature, and are highly protective of constitutionally enshrined civil liberties, the Indian judicial system, like the British and Canadian systems, tends to exhibit a culture of deference to Parliament.

 

LOS CORREOS DEL CDC (USA) SOBRE SUS CAMBIOS DE LA DEFINICIÓN DE "VACUNA"

https://gruizlegal.blogspot.com/2022/07/los-correos-del-cdc-usa-sobre-sus.html

Emails Confirm Why CDC Changed Definitions of Vaccine, Vaccinated 

 

 Newly obtained emails confirm that the Centers for Disease Control and Prevention (CDC) changed its definition for both “vaccine” and “vaccinated” because people were pointing out that the definitions didn’t seem to apply to the COVID-19 vaccines.

 “The definition of vaccine we have posted is problematic and people are using it to claim the COVID-19 vaccine is not a vaccine based on our own definition,” Alycia Downs, a CDC official, wrote in an email to a colleague on Aug. 25, 2021. The definition is located on the CDC webpage on immunization basics. 

 “Vaccine” had been defined since at least 2011 by the CDC as a product that triggers immunity, while “vaccination” was described as an injection that prevents a disease, according to archived versions of the page. However, a flood of inquiries on the definitions was triggered by the fact that the COVID-19 vaccines have been increasingly ineffective against infection by the virus that causes COVID-19, the emails show. 

 “Our question is how is the CDC and the rest of the world allowed to call the shot a vaccination when it doesn’t even meet your own definition,” one person wrote to the CDC. 

 

 “Right-wing covid-19 pandemic deniers are using your ‘vaccine’ definition to argue that mRNA vaccines are not vaccines,” another said. 

 

 The Pfizer and Moderna COVID-19 vaccines are both built on messenger RNA technology. They’re two of the three COVID-19 vaccines available in the United States. 

 

 Downs and colleagues Allison Michelle Fisher, Cynthia Jorgensen, Valerie Morelli, and Andrew (no last name given) worked on changing the definitions for “vaccine” and “vaccination,” according to the emails.

 

The changes were pushed through on Aug. 31, 2021, and Sept. 1, 2021, respectively.

 

Changing Definitions

“Vaccine” is now defined as “a preparation that is used to stimulate the body’s immune response against diseases.

“Vaccines are usually administered through needle injections, but some can be administered by mouth or sprayed into the nose,” the definition reads.

The previous definition was “a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose.”

“Vaccination” was changed to “the act of introducing a vaccine into the body to produce protection from a specific disease” from “the act of introducing a vaccine into the body to produce immunity to a specific disease.”

 The Epoch Times has obtained the emails and additional messages concerning the changes and has published all 67 pages of them.

The batch of emails, obtained through a Freedom of Information Act request, also shows that Andrew, a CDC employee on the agency’s Vaccine Task Force, boosted a Washington Post article that downplayed criticism of the change.

EL INFORME DEL TRIBUNAL DE CUENTAS EUROPEO SOBRE LOS CONTRATOS DE LAS VACUNAS COVID-19

https://gruizlegal.blogspot.com/2022/09/el-informe-del-tribunal-de-cuentas.html

La Comisión firmó contratos por valor de 71 000 millones euros para entregas de hasta 4 600 millones de dosis de vacunas contra el COVID-19 Los Estados miembros acordaron reducir los riesgos de los fabricantes relacionados con la responsabilidad por efectos adversos -principio de reparto de riesgos en la estrategia de vacunación 

Las disposiciones de los contratos celebrados con los fabricantes devacunas contra el COVID-19 difieren de la práctica anterior a la pandemia, ya que los Estados miembros han asumido algunos de los riesgos financieros que normalmente recaen sobre los fabricantes de vacunas 

La Comisión y los Estados miembros consideraron que la introducción temprana de la vacuna redundaba en interés de la salud pública. Por lo tanto, los Estados miembros estaban dispuestos a reducir los riesgos de los fabricantes relacionados con la responsabilidad por efectos adversos. Esto se concibió como un principio de reparto de riesgos en la estrategia de vacunación. Aunque respetan el principio general de responsabilidad con arreglo a la Directiva sobre responsabilidad por los daños causados por productos defectuosos (véase el recuadro 1), las disposiciones de los contratos celebrados con los fabricantes de vacunas contra el COVID-19 difieren de la práctica anterior a la pandemia (véase el recuadro 1), ya que los Estados miembros han asumido algunos de los riesgos financieros que normalmente recaen sobre los fabricantes de vacunas.

 Recuadro 1 

La Directiva de la UE sobre responsabilidad por los daños causados por productos defectuosos 

 Con arreglo a la Directiva sobre responsabilidad por los daños causados por productos defectuosos, los productores son responsables de los daños causados por un defecto de su producto, aunque no haya negligencia o culpa por su parte. Un productor puede quedar exento de tal responsabilidad si, en el momento en que el producto fue puesto en circulación, el estado de los conocimientos científicos y técnicos no permitía descubrir la existencia del defecto. Un ciudadano de la UE que sufra efectos adversos graves a causa de un medicamento puede presentar una reclamación de indemnización por daños y perjuicios contra el fabricante con arreglo a la Directiva, que ha sido incorporada a la legislación de los Estados miembros. 

 Un ciudadano que haya sufrido efectos adversos de una de las vacunas contra el COVID-19 adquiridas en virtud de los contratos puede ejercitar una acción de daños y perjuicios contra el fabricante de la vacuna. Si la acción prospera, el Estado miembro que administró la vacuna será responsable de indemnizar a la parte perjudicada y de pagar los gastos legales del fabricante de la vacuna (indemnización) (véase la ilustración 3). 

Este no es el caso si los daños o pérdidas se deben a una conducta dolosa o al incumplimiento de las buenas prácticas de fabricación de la UE. Además de las reclamaciones en virtud de la Directiva sobre responsabilidad por los daños causados por productos defectuosos, según un estudio reciente11, once Estados miembros cuentan con regímenes nacionales de indemnización «sin culpa» para resarcir a los perjudicados por los daños sufridos como consecuencia de los efectos secundarios causados por una vacunación. Estos regímenes no exigen que la persona perjudicada demuestre la existencia de un nexo causal entre el efecto secundario y la vacuna. Una persona que opte por recibir dicha indemnización pierde el derecho a presentar una demanda contra la empresa farmacéutica.

ONCE ESTADOS MIEMBROS : Austria, Denmark, Finland, France, Germany, Hungary, Iceland, Italy, Luxembourg, Norway, Russia, Latvia, Slovenia, Sweden, Switzerland, United Kingdom

INFORME SOBRE EL ORIGEN DEL COVID-19 ENVIADO AL SENADO Y CONGRESO DE ESTADOS UNIDOS (12-09-2022)

https://gruizlegal.blogspot.com/2022/09/informe-sobre-el-origen-del-covid-19.html

Report about the REAL Origin of SARS-CoV2 sent to the US Senate and Congress last week

 I declare (or certify, verify, or state) under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.

 Executed On (Date): ______________ Signature: ______________________ 

Andrew G. Huff, Ph.D., M.S."

 

September 12, 2022

Donald Trump, Senator Ron Johnson, Senator Rand Paul, Rep. Jim Jordan, and others were right. As early as late April or early May of 2020 former President Trump spoke of the creation of SARS-COV2 in a lab in Wuhan, China. Since that time both the investigation and the cover-up have continued but the evidence provided herein clearly demonstrate that SARS-COV2was indeed created in a lab in Wuhan China by EcoHealth Alliance and with funding fromAnthony Fauci’s NIH/NIAID.

Evidence included herein demonstrate the following key points (amongst others):

1. SARS-COV2 was created in the lab in Wuhan, China;

2. Anthony Fauci funded the creation of SARS-COV2 and lied to Congress about funding Gain-of-Function work;

3. The US Intelligence Community was aware of and appeared to have been involved with the funding of said Gain-of-Function work;

4. A number of well-connected public and private partners were involved in the Gain-of-

Function work that resulted in the creation and release of SARS-COV2;

5. Anthony Fauci and others coordinated to cover-up the funding of the Gain-of-Function

work that resulted in SARS-COV2.

 

Given the recent high-profile criminal enforcement actions taken by Congress and the DoJ, we expect immediate investigations will see bi-partisan support in light of this newly compiled information. Renz Law and Make Americans Free Again (MAFA) will provide any and all support possible in such investigations and prosecutions. Further, with the additional high-profile revelations that certain segments of the government have promoted censoring this information, presumably as part of this same cover-up, we will voluntarily support any good-faith efforts by the media to correct the record.

As has been the case since early in the pandemic, Renz Law and MAFA will continue to seek truth and justice in this matter for all that have been impacted by the worst man-made pandemic in human history.

Sincerely,

Thomas Renz

Renz Law, LLC

 

LOS DOCUMENTOS CRITICOS DE LOS ACUERDOS ENTRE PFIZER Y LA UE (6-10-2022, (I))

https://gruizlegal.blogspot.com/2022/10/los-documentos-criticos-de-los-acuerdos.html

The signed November 2020 Advance Purchase Agreement (APA) between the EU member states and Pfizer/BioNTech. This appears to be genuine, but has not been independently verified.

The 59 page contract and the 45 pages of attachments can be found here:

 https://maloneinstitute.org/pfizer-biontech

Quoted text directly from the Agreement:

1.1.1 Quality tests and checks The Contractor shall perform all bulk holding stability, manufacturing trials, validation (including, but not limited to, method, process and equipment cleaning validation), raw material, in-process, bulk finished product and stability (chemical or microbial) tests or checks required to assure the quality of the Product and tests or checks required by the Specifications and Good Manufacturing

11.6.4 Limits on liability

(i)             Taking into account the unprecedented nature of the current COVID-19 situation and the exceptional circumstances under which the Vaccine shall be delivered, the parties explicitly agree that the Contractor and its Affiliates cannot be held liable for any damages except for proven damages which are suffered by the Commission or the Participating Member States as a direct consequence of a breach by the Contractor or its Affiliates of its obligations under this APA or a Vaccine Order Form, and that the Contractor and its Affiliates shall in any case not be liable for late deliveries (subject to the Contractor's obligation to use Best Reasonable Efforts as contained in Article 1.6.3), loss of revenue, loss of anticipated savings, loss of business, loss of profit, loss of goodwill, reputational damages, loses from economic disruption or cost of alternative supply.

11.6.4         No limitation of liability

(i)             Nothing in this APA excludes or limits the liability of either party for:

(a)                       wilful intent, fraud or fraudulent misrepresentation;

(b)                      any breach of Article 11.9 (Confidentiality);

(i)             Nothing in this APA excludes or limits the liability of either party for:

(a)                       wilful intent, fraud or fraudulent misrepresentation;

(b)                      any breach of Article 11.9 (Confidentiality);

(1.12.1) The Commission, on behalf of the Participating Member States, declares that the use of Vaccines produced under this APA will happen under epidemic conditions requiring such use, and that the administration of Vaccines will therefore be conducted under the sole responsibility of the Participating Member States. Hence, each Participating Member State shall indemnify and hold harmless the Contractor, their Affiliates, sub­ contractors, licensors and sub-licensees, and officers, directors, employees and other agents and representatives of each (together, the "Indemnified Persons") from and against any and all liabilities incurred, settlements as per Article I.12.6, and reasonable direct external legal costs incurred in the defence of Third Party Claims (including reasonable attorney's fees and other expenses) relating to harm, damages and losses as defined in Article I.12.2 (together, the "Losses") arising from or relating to the use and deployment of the Vaccines in the jurisdiction of the Participating Member State in question.    

1.12.8 The parties explicitly agree that:

(i)             any warranties given by the Contractor, whether express or implied, under this APA as regards compliance with Good Manufacturing Practice or conformity of the Product with the Specifications shall be without prejudice to the provisions of this Article I.12, which shall apply independently of and prevail over such warranties, including any (claimed) breach of such warranty; and

a Participating Member State does not have the right to suspend and/or otherwise not perform its obligations under this clause

except where the Participating Member State puts forward reasonable evidence that one of the situations listed in this Article I.12.1(i) and (ii) is applicable and the matter is brought for dispute resolution under Article I.13

ANNEX Ill: PARTICIPATING MEMBER STATES

Germany France Italy Spain Austria Greece Cyprus Malta Denmark Sweden Finland Ireland Portugal Belgium Luxembourg Netherlands Poland Romania Bulgaria Slovenia Croatia, Czech Republic Hungary Slovakia Lithuania Latvia Estonia

GEERT VANDEN BOSSCHE (8-10-2022): ÚLTIMO (Y DEFINITIVO) VIDEO SOBRE LA DESASTROSA EVOLUCIÓN DEL COVID-19

https://gruizlegal.blogspot.com/2022/10/geert-vanden-bossche-8-10-2022-ultimo-y.html

In fact, we are already too late to intervene in a way that could prevent humanitarian crisis. It is really my last and desperate call for action as Omicron is now causing a fast and large-scale immune escape in vaccines. So, this is simply accelerating. 

 

Immune escape is accelerating. It is really escalating and for me it is really unbelievable. I cannot understand how it is possible that all these researchers that are studying these mutations and this mutational escape of the virus are not ringing the alarm bell. So I don't know, I really don't know. Is it stupidity or is it really willful blindness? The scientists who are analyzing all these new mutations that are simply accumulating, we have seen them accumulating even over the last days, over the last weeks. For the scientists, this doesn't seem to be a reason for panic really. I mean, they see this fulminant immune escape as in fact a great opportunity for making publications. 

 

When humanity is on the brink of humanitarian crisis, we need to gather information that is able to predict with a high level of fidelity, with a high level of confidence what is going to happen. And they are not able to do this simply because they don't see the forest for the trees. And why is this? And here comes the thing. It is simply because they don't understand the underlying immune interaction between the virus and the immune system. They all agree that the convergent evolution of what they call themselves worrisome variants and the resulting immune escape, that all this is due to immune selection pressure that is placed on the virus. All this is very, very clear to them. But nobody dares to mention that this huge immune selection pressure has to do with the mass vaccination. I cannot believe this. And it's even worse: On the contrary, these scientists who are excelling in what I call molecular stamp collection, these are the guys who are now also advocating for the development of broad-spectrum vaccines and antibody drugs. So continuation, please, with the vaccine program. And so, when I'm talking about the molecular stamp collection, I'm showing here a graph. 

 

 So by hiding the stronger neutralizing epitopes, the subdominant epitopes now gain, immunologically speaking, a competitive advantage. However, these less exposed domains of spike are less potent inducers of neutralizing antibodies. Now, in case somebody has been vaccinated and that is what we are talking about in case of breakthrough infections, , these subdominant epitopes now gain a competitive advantage and will be able to recall previously primed B memory cells that are producing antibodies which have a lower neutralizing capacity. So the subdominant epitopes that gain a competitive advantage because the strongest neutralizing epitopes have now been hidden by the existing preexisting vaccinational antibodies, are now going to be able to recall in a pre-primed, i.e., a vaccine-primed individual, previously primed antibodies or memory cells that are producing antibodies that have less neutralizing capacity. That is what I'm calling here the ‘hidden antigenic sin’. Why hidden? Because they are not promoting the stimulation, so to say, of the original vaccinal antibodies, despite reinfection. No, they are eliciting antibodies that were not previously elicited or that were only elicited in very, very low quantities because the antigens that were inducing them were dominated and outcompeted by the stronger neutralizing epitopes. So now we get to a situation where these subdominant epitopes are recalling antibodies with less neutralizing capacity. And this will lead in fact to a situation where breakthrough infections are causing an increased proportion of poorly neutralizing to even non neutralizing antibodies. And that is the system that will expedite and accelerate immune escape as never seen before. 

 

So, what is the conclusion of this? Well, in fact, the conclusion, if you think about this, is that the emerging omicron variants, by virtue of causing breakthrough infections, are putting themselves under growing immune pressure because they are recalling vaccine-induced antibodies with decreasing neutralizing capacity. So, you can already imagine that when these Omicron variants circulate and you get these breakthrough infections over and over again, that this will lead to a vicious circle which is going to escalate the rate of immune escape. It already explains, of course, why also updated vaccines, so to say adapted to Omicron, are a complete nonsense. This is an insult to the science. How can you be so stupid? It can only be if you have no clue about this mechanism of immune refocusing. And there are now many, many publications that describe the evolution of how the immune response is getting enriched in poorly neutralizing and non-neutralizing antibodies. And all of these data are completely compatible with this theory of immune refocusing and hidden antigenic sin. 

 

So, because of that, we are seeing now converging receptor-binding domain mutations, so, mutations in the receptor binding domain that are now even enhancing the infectiousness of the virus. So, you first have poorly neutralizing antibodies that are promoted, so to say, or that are recalled, then they are less and less neutralizing, even non-neutralizing. And at the end, what is going on right now as we speak, is that we see in all these variants converging mutations in the receptor-binding domain that are now even enabling enhanced infectiousness of the virus. So I cannot believe this, that there are professors, leaders of institutes for molecular biology, genetics, et cetera, et cetera who come up with the type of statements shown in this slide. And when I see their argumentation or their reasoning, what could possibly be the pluses and the minuses, the pros and cons of these Omicron-adapted vaccines, these updated vaccines, I mean, this is a shame. 

 

 And I would say to the fact checkers, please wait. If you want to vilify me or ridicule me, that's fine. But just wait for the next few weeks or months to see what is happening because I am going to predict what is happening. So if that happens, at that moment we will see that immune escape will cause what we call ‘antibody dependent – (because it's depending on those antibodies)- enhancement of severe disease’. And that is going to be a real catastrophe. If you look at the COVID-19 hospitalizations and you compare the unvaccinated versus the vaccinated. So, at some point the hospitalizations for the unvaccinated were in higher numbers than for the vaccinated. I mean, this evaluation has never been fair because I always the unvaccinated, they needed hospitalization because of underlying diseases and those underlying diseases were predisposing them of course to Covid-19 whereas the vaccinated, they needed hospitalization because of the vaccination, because of the side effects but because of the vaccination they were of course also protected against severe disease. So, it was never fair to compare unvaccinated and vaccinated just within hospitalized population. But nevertheless, so what we will see is that, and it is going on already, the numbers of the (hospitalized) unvaccinated will drop and will continue to drop, whereas for the (hospitalized) vaccinated, the number of hospitalizations will strongly increase (and it's already starting to increase), but it will have an exponential course. And of course people say, yeah, that's logical because most of the people are vaccinated. So, there's more people landing in hospitals that have severe disease. 

 

Oh, wait a minute, we can do also the ratios, we can do the ratio of hospitalizations in the unvaccinated versus the vaccinated, right? And if we build that ratio and then we compare how this ratio is changing for example between T2 versus T1, i.e., an earlier time point. Well what we will see is that we will have a very dramatic decrease in this ratio, indicating -again that the rate of hospitalization for severe disease in the vaccinated will dramatically increase; we will be able to follow this evolution very easily. So what does it mean in fact for vaccinees? Well first of all we have already seen that they have enhanced susceptibility to infection and we first see this of course with the elderly, the people who have been vaccinated first, who have gotten all their booster shots: third, the fourth, the fifth, you name it. What we will see thereafter, and this is starting to begin right now, is that we will see enhanced susceptibility to COVID-19 disease, not whatever other disease but COVID-19 disease. Of course first in the elderly and then what will follow is enhanced susceptibility of these vaccinees to severe C-19 disease. And so how this will translate practically speaking is that vaccinees who get infected will get C-19 disease but upon reinfection the very same vaccinees will now get severe disease. 

 

 So, this is my desperate call for taking drastic and immediate action. So, what could we do? What could we still do? Well of course I was explaining we need to avoid this immune refocusing because this is just going to throw additional fuel on the fire because this is going to escalate and accelerate the immune escape in a direction that is really very detrimental, that will end up in enhanced virulence of a highly infectious virus. So, we cannot give new booster doses like Omicron-updated booster doses. Of course, the infection rate can only be reduced via chemoprophylaxis with safe and effective antivirals that on top are broadly accessible and affordable. So, I don't care which antivirals but they need to comply with those criteria. And we know that there are only very, very few drugs that have these properties that are really safe, can do the job, are effective, broadly accessible and affordable. And I tell you, I think this will need to be done in a prophylactic way. We will need to do it right now in highly vaccinated countries and start providing people massively with antivirals. And the reason I'm saying this is that preventing these vaccine breakthrough infections is almost like generating herd immunity. If we can avoid these vaccine breakthrough infections we can start to build herd immunity. And please remember: the only way, the only way to control and terminate a pandemic is by generating herd immunity. So then, how long would we need to give these antivirals? Forever? No, we would not do this because that would also have a risk of, for example, inducing (drug) resistance. We would need to do this till we have achieved full herd community. 

 

Of course, for the unvaccinated it's much easier. They have trained their natural immunity. I keep saying the unvaccinated will do better and better, will ultimately become resistant to this virus. And the people who are probably best protected against Sars-Covid-2 and all the upcoming variants are those that are unvaccinated and live in highly vaccinated countries. 

 

These are the only two options that we have to diminish this fulminant transmission rate in the population that we see right now and that could lead to this miraculous target that was in fact the purpose of the mass vaccination campaign, which miserably failed, and which is herd immunity. So, what about the side effects and all post mortality rates in the vaccinees that we have seen have been going up? It's appalling if you see the rates and the kind of side effects, the kind of increase in excess deaths, etc. I have no words to describe it; really. It's appalling, it is unacceptable, it blows me away. But nevertheless, whether you believe me or not, I'm always saying: if one puts all these side effects and all this excess death rate together, it is still going to be peanuts compared to the kind of losses that we are going to face when the virus evolves as I'm predicting, and which I'm 200% certain of, that it will evolve in that way. 

 

And what about the updated Omicron adapted vaccine? Well, I told you that in the unvaccinated it will enable immune refocusing and in the vaccinees, it will enhance it, so it will make the situation dramatically worse. It will escape. 

 

And the winning party is not going to be the technocrats, it's not, let's say, the megalomania of mankind, but it's simply the biology. And these experts, these scientists have forgotten about biology. They are blinded by technologies, whether it's for diagnostics, whether it's for surveillance, whether it's for therapeutic purposes, whether it's for preventive purposes. They have forgotten about the essentials of biology. 

 

And that is also why I'm saying, with regard to the COVID-19 battle, the country or the continent that will win is Africa. Because they will build herd immunity. So, with that, as I was saying, my desperate last video message to call on people who are in charge to still intervene in a way that we can limit the losses and the kind of humanitarian crisis that I think we are now really, really facing very closely.

 

LA HUELLA DE ENDONUCLEASA INDICA UN ORIGEN SINTÉTICO DEL SARS-Cov-2 (I)

https://gruizlegal.blogspot.com/2022/10/la-huella-de-endonucleasa-indica-un.html

¿ES EL SARS-Cov-2 UN VIRUS ONCOGÉNICO?

https://gruizlegal.blogspot.com/2022/10/es-el-sars-cov-2-un-virus-oncogenico.html

Recently, in this journal, Wu et al. (1) and Gao et al. (2) have both indicated that host genetic variation related to COVID-19 might be associated to endometrial cancer. We here add evidence from gene expression analysis supporting that the connection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cancer could be more general, in line with several other viral infections that represent serious risks for carcinogenesis in humans. The SARS-CoV-2 has developed similar strategies to Epstein-Barr virus (EBV) and hepatitis B virus (HSV1) to control p53 by hijacking the protein via virus antigens, and ultimately leading to its degradation (3,4). Specifically, the Nsp2 viral protein of the SARS-CoV-2 interacts with the prohibitin 1 and 2 (PHB1, PHB2) that are primarily located in the mitochondrion and play an essential role in maintaining mitochondrial DNA activity. Their depletion triggers a chain of cell responses that lead to a leakage of reactive oxygen species (ROS) to the nucleus and oxidative damage, that ultimately provokes the impairment of the transactivation of p53-dependent genes. In addition, the Nsp3 SARS-CoV-2 protein binds and activates the RING finger and CHY zinc finger domain-cotainin protein 1 (RCHY1) and E3 ubiquitin ligase, promoting p53 degradation (5). Therefore, SARS-CoV-2 has the ability to trigger external and internal apoptotic pathways of the host cells, facilitating its spread. Impairment of p53 could be seen as a strategy of the virus to take advantage of the cell pathways controlled by this protein for its own benefit during acute phase of infection, therefore evading host immune response and facilitating its replication (3). In this context, a reduced expression of p53 during the acute phase of infection is also a biomarker of severe disease.

Although it has not been demonstrated yet, it has been hypothesized that a long-term inhibition of p53 by the SARS-CoV-2 could be carcinogenic. The onco-suppressive protein p53 is a key player within the apoptotic signaling pathway and regulates the expression of about 500 target genes; therefore, it plays a role in cell cycle arrest, cell aging, cell death, etc. (6). We examine three gene expression datasets to demonstrate that p53 is downregulated during acute SARS-CoV-2 infection and long coronavirus-disease 19 (COVID-19); a long-term reduction of p53 could be interpreted as a risk factor in carcinogenesis.

 

SUSPENSIÓN CAUTELAR DE VACUNACIÓN COVID-19 EN ARGENTINA (HASTA 16 AÑOS, (I))

https://gruizlegal.blogspot.com/2022/12/suspension-cautelar-de-vacunacion-covid.html

Poder Judicial de la Nación

JUZGADO FEDERAL DE MAR DEL PLATA 4

14056/2022 ARRILLO COUHEZ, MARIA ALICIA NOEMI Y OTROS c/ PODER EJECUTIVO

NACIONAL Y OTRO s/AMPARO COLECTIVO -SB/LC/JGI/VC

Mar del Plata, 30 de noviembre de 2022.

(…)

 

XII) Por ello, considerando los extremos que han sido abonados en autos, la particular situación descripta en torno al carácter no obligatorio y los argumentos esgrimidos por ambas partes, sus abogados representantes y especialistas que han participado de ambas instancias orales, he de disponer una medida cautelar innovativa, en los siguientes términos:

Sin que implique prejuzgamiento respecto del fondo de la cuestión traída a debate, bajo entera responsabilidad de los accionantes y previa caución juratoria que se entiende prestada con la demanda inicial, DECRETASE MEDIDA CAUTELAR INNOVATIVA ordenando LA SUSPENSIÓN DE LA PROMOCIÓN DE LA CAMPAÑA/PLAN DE VACUNACIÓN contra Covid-19 en bebés y niños cuyo rango etario se encuentre comprendido entre los seis meses y 16 años de edad, establecido por el Decreto 431/202111 (Mod. de la ley 27.573) hasta tanto se verifique por parte de los codemandados PODER EJECUTIVO NACIONAL - MINISTERIO DE SALUD DE LA NACION la implementación de las medidas necesarias a fin de garantizar el acceso a la información relacionada a los efectos de la inoculación de aquellas vacunas contra covid-19 autorizadas para su distribución en nuestro país, en particular de los efectos adversos, contraindicaciones, riesgos conocidos y potenciales, al momento de la inoculación, dirigida a cada representante legal de los menores - o quien se encuentre a su cargo - de forma fehaciente.

A tal fin, se dispone que la medida sea cumplimentada en debida articulación con las autoridades sanitarias provinciales y municipales, quienes tienen a su cargo la implementación operativa del Plan referido, respecto de los cuales quedará a cargo de las codemandadas la obligación de su notificación, con posterior acreditación en los presentes actuados, evitando dilaciones que pudiesen comprometer los derechos de los actores.

Asimismo, dado que durante el transcurso de la audiencia informativa llevada adelante ha quedado en claro que en el caso de otras vacunas no existe una norma expresa que prevea un Fondo de Reparación12 destinado a indemnizar a aquellas personas que, eventualmente, padezcan un daño en la salud como consecuencia directa de su aplicación, siendo que el propio Estado Nacional ha vislumbrado la posibilidad de eventuales efectos nocivos de la inoculación de la vacuna covid-19, es que considero necesario incluir entre la información referida, la correspondiente a dicho Fondo, a fin de que los representantes legales de los menores – o quien se encuentre a su cargo - tomen conocimiento acabado de su existencia y los mecanismos para acceder al mismo.

Todo ello hasta tanto se resuelva la cuestión de fondo y/o dicte sentencia definitiva en los presentes.

 

SUSPENSIÓN CAUTELAR DE VACUNACIÓN COVID EN ARGENTINA (HASTA 16 AÑOS, (II))

https://gruizlegal.blogspot.com/2022/12/suspension-cautelar-de-vacunacion-covid_19.html

 

UNA PROPOSICIÓN DE LEY (USA) PARA ELIMINAR LA AUSENCIA DE RESPONSABILIDAD POR LOS DAÑOS DE LAS VACUNAS COVID (I)

https://gruizlegal.blogspot.com/2022/12/una-proposicion-de-ley-usa-para.html

A BILL

To amend titles III and XXI of the Public Health Service
Act to hold vaccine manufacturers liable for injuries
caused by vaccines subject to a public mandate, and
for other purposes.
1 Be it enacted by the Senate and House of Representa2
tives of the United States of America in Congress assembled,
3 SECTION 1. MANDATED VACCINE MANUFACTURER LIABIL

4ITY.
5 (a) PANDEMIC AND ENDEMIC PRODUCTS.—Section
6 319F–3(d) of the Public Health Service Act (42 U.S.C.
7 247d–6d(d)) is amended—

(...)

‘‘(2) VACCINES.—The immunity from suit and
9 liability of covered persons set forth in subsection
10 (a) shall not apply with respect to the administration
11 of a vaccine licensed under section 351 or authorized
12 for emergency use under section 564 of the Federal
13 Food, Drug, and Cosmetic Act if any agency of the
14 Federal Government, any official of the Government,
15 any agency of any State government, any official of
16 any state government, or any entity that receives
17 Federal or State funding, either directly or indi

18rectly, requires the administration of such vaccine or
19 provides for any penalty or loss of privileges for the
20 refusal to consent to administration of such vac

21
cine.’’.

 
22 (b) VACCINE INJURY COMPENSATION PROGRAM.—
23 Section 2111(a)(2) of the Public Health Service Act (42
24 U.S.C. 300aa–11(a)(2)) is amended—

 

16 (c) VACCINE INJURY TABLE.—Section 2114(c) of the
17 Public Health Service Act (42 U.S.C. 300aa–14(c)) is
18 amended—
19 (1) in paragraph (1), by inserting ‘‘and subject
20 to paragraph (5)’’ after ‘‘paragraph (3)’’; and
21 (2) by adding at the end the following:
22 ‘‘(5) Beginning on the date of the enactment of this
23 paragraph, the Secretary may not add a vaccine to the
24 Vaccine Injury Table if —

1 ‘‘(A) the administration of such vaccine is re

2quired by any agency of the Federal Government,
3 any official of the Government, or any entity that re4
ceives Federal funding, either directly or indirectly;
5 and
6 ‘‘(B) the vaccine was administered—

7 ‘‘(i) without first obtaining from the per

8son receiving the vaccine the informed consent
9 of that person; or

10 ‘‘(ii) without such person being provided a
11 religious or medical exemption if a request was
12 made for such an exemption.’’

 

Rep. Gohmert Introduces Bill to hold Big Pharma Liable for Injuries Caused by Publicly Mandated Vaccines

 Rep. Louie Gohmert (TX-01) released the following statement after introducing a bill to eliminate liability protection for companies when their vaccines are subject to public mandates:

“The immense human suffering our country experienced due to the disgraceful COVID-19 vaccine mandates must never happen again,” said Rep. Gohmert. “Through their reckless edict, the Biden Administration forced many Americans to choose between maintaining their livelihoods and protecting their bodily autonomy from an experimental vaccine—one that we now have come to learn does not protect against infection or transmission. Even more important than the financial ruin the mandates have caused to so many Americans are the clear and present dangers these vaccines can pose to the health and safety of those who have received it. 

“If the United States government wishes to force Americans to take an experimental vaccine, the U.S. Constitution and human rights norms dictate that it must make the case and convince Americans that it is safe and effective, respecting informed consent and the right to refuse.  If the U.S. government refuses to honor even the most basic individual right in such matters, then no reasonable person would argue that there should also be immunity from liability for the very products being forced into the populace.  This bill would rightly eliminate liability protection for pharmaceutical manufacturers for any vaccine subject to a mandate. It is time pharmaceutical companies stand behind their products and face accountability when necessary.”